Cargando…
Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437698/ https://www.ncbi.nlm.nih.gov/pubmed/34529994 http://dx.doi.org/10.1053/j.gastro.2021.09.019 |
_version_ | 1783752209162305536 |
---|---|
author | Chapman, Thomas P. Revés, Joana Torres, Joana Satsangi, Jack |
author_facet | Chapman, Thomas P. Revés, Joana Torres, Joana Satsangi, Jack |
author_sort | Chapman, Thomas P. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8437698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | by the AGA Institute |
record_format | MEDLINE/PubMed |
spelling | pubmed-84376982021-09-14 Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY? Chapman, Thomas P. Revés, Joana Torres, Joana Satsangi, Jack Gastroenterology Selected Summaries by the AGA Institute 2021-12 2021-09-14 /pmc/articles/PMC8437698/ /pubmed/34529994 http://dx.doi.org/10.1053/j.gastro.2021.09.019 Text en © 2021 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Selected Summaries Chapman, Thomas P. Revés, Joana Torres, Joana Satsangi, Jack Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY? |
title | Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY? |
title_full | Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY? |
title_fullStr | Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY? |
title_full_unstemmed | Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY? |
title_short | Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY? |
title_sort | anti–sars-cov-2 antibody responses in patients with ibd treated with biologics: are we finding clarity? |
topic | Selected Summaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437698/ https://www.ncbi.nlm.nih.gov/pubmed/34529994 http://dx.doi.org/10.1053/j.gastro.2021.09.019 |
work_keys_str_mv | AT chapmanthomasp antisarscov2antibodyresponsesinpatientswithibdtreatedwithbiologicsarewefindingclarity AT revesjoana antisarscov2antibodyresponsesinpatientswithibdtreatedwithbiologicsarewefindingclarity AT torresjoana antisarscov2antibodyresponsesinpatientswithibdtreatedwithbiologicsarewefindingclarity AT satsangijack antisarscov2antibodyresponsesinpatientswithibdtreatedwithbiologicsarewefindingclarity |